肺部康复对慢性阻塞性肺病全身炎症的影响:一个元分析
Xiaotian Alex Yue1, Yilan Sheng2, Jianhua Li1
1Department of Rehabilitation, Shanghai General Hospital, Shanghai Jiaotong University Shanghai, China.
American journal of clinical and experimental immunology
|March 18, 2024
概括
慢性阻塞性肺部疾病 (COPD) 的肺部康复 (PR) 可能会意外地增加 IL-6,CRP 和 TNF-alpha 等炎症标志物. 进一步的分析表明,这些发现可能受到特定研究的影响,质疑PR的抗炎作用.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 生物标志物 生物标志物
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及全身炎症.
- 肺部康复 (PR) 是一种关键的COPD治疗方法,但其系统性炎症效应尚未完全理解.
研究的目的:
- 通过元分析评估PR对COPD患者循环炎症标志物的影响.
主要方法:
- 对RCT和观察性研究的PubMed,EMBASE和Web of Science的系统审查.
- 使用随机效应模型进行元分析,以计算炎症标志物的平均差异.
- 偏差风险评估和敏感性分析.
主要成果:
- 包括6项研究 (4项RCT,2项观察性) 涉及147名COPD患者.
- 在PR后观察到IL-6,CRP和TNF-alpha的显著增加.
- 敏感性分析表明,一项研究对结果产生了很大的影响;其排除使得变化无关紧要.
结论:
- 这项元分析发现,在COPD患者中,PR后炎症标志物意外增加.
- 假设PR对COPD的抗炎功效需要进一步调查.
- 研究结果强调需要仔细解释PR的系统效应.
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
205
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
205


